Scarica l'app Stockscreener
1.78
3.89%
-0.072
Dopo l'orario di chiusura:
1.91
0.13
+7.30%
Autonomix Medical Inc Borsa (AMIX) Ultime notizie
Autonomix Medical announces inducement grant - Medical Buyer
Autonomix Medical, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Autonomix Medical Expands Team with Strategic 5,000-Share Stock Option Grant to New Key Employee - Stock Titan
Autonomix Medical secures new European patent for nerve tech By Investing.com - Investing.com South Africa
Autonomix Medical Granted European Patent For Catheter-Based Neuromodulation Technology - Nasdaq
Autonomix Medical Gains European Patent for Catheter-Based Tech - Medical Product Outsourcing
Autonomix Medical secures new European patent for nerve tech - Investing.com
Autonomix Medical Granted New European Patent For Proprietary Catheter-Based Technology - marketscreener.com
Autonomix Medical, Inc. Granted New European Patent for Proprietary Catheter-Based Technology - GlobeNewswire
Autonomix stock plunges to 52-week low of $1.52 amid steep annual decline - Investing.com Australia
Autonomix stock plunges to 52-week low of $1.52 amid steep annual decline By Investing.com - Investing.com South Africa
Analyzing Globus Medical (NYSE:GMED) & Autonomix Medical (NASDAQ:AMIX) - Defense World
Autonomix to begin U.S. clinical studies for FDA approval By Investing.com - Investing.com South Africa
Autonomix to begin U.S. clinical studies for FDA approval - Investing.com
Autonomix Medical, Inc. Engages Leading Medical Experts to - GlobeNewswire
Top Medical Experts Join Forces to Advance Revolutionary Pancreatic Cancer Pain Treatment - Stock Titan
Autonomix Medical, Inc. to Highlight Technology and Early Proof-of-Concept Study Results in a Poster Presentation at the 2025 European Conference on Interventional Oncology (ECIO) - GlobeNewswire
Revolutionary Pancreatic Cancer Pain Treatment: Autonomix Medical Reveals First Clinical Results at ECIO 2025 - Stock Titan
Autonomix Medical, Inc. (NASDAQ:AMIX) Short Interest Update - Defense World
Patent Granted to Autonomix Medical for Sensing Data Collection - Medical Product Outsourcing
Autonomix stock plunges to 52-week low of $1.81 amid market challenges By Investing.com - Investing.com South Africa
Autonomix stock plunges to 52-week low of $1.81 amid market challenges - Investing.com Australia
Financial Analysis: INVO Bioscience (NASDAQ:INVO) & Autonomix Medical (NASDAQ:AMIX) - Defense World
Autonomix Medical announces inducement grant under Nasdaq listing rule 5635(C)(4) - Marketscreener.com
Autonomix Medical Awards Strategic Stock Options Package Under Nasdaq Rules - StockTitan
Can Autonomix Sensing And RF Ablation System Prove Its Mettle In Managing Pancreatic Cancer Pain? - RTTNews
Autonomix Medical Granted US Patent for Catheter-Based Technology; Shares Up 10% Pre-Bell - Marketscreener.com
Autonomix Medical Expands Patent Portfolio with New Issuance for Innovative Sensing and Ablation Technology - Nasdaq
Autonomix Medical, Inc. Granted U.S. Patent Covering Sensing Data Collection and Processing with Company's Proprietary Catheter-Based Technology - The Manila Times
Autonomix Medical, Inc. Granted U.S. Patent Covering - GlobeNewswire
Groundbreaking Patent: Autonomix Medical's New Tech 3000x More Sensitive Than Current Solutions - StockTitan
Head to Head Analysis: Autonomix Medical (NASDAQ:AMIX) versus SI-BONE (NASDAQ:SIBN) - Defense World
Autonomix Medical, Inc. (NASDAQ:AMIX) Sees Significant Decline in Short Interest - Defense World
Autonomix Medical finalizes ASIC microchip design - MSN
Autonomix advances pancreatic cancer treatment system - Investing.com Australia
Autonomix Medical Advances Toward US Clinical Trials In 2025 With Apex 6 Generator Integration - Nasdaq
Autonomix advances toward U.S. clinical trials in 2025 - TipRanks
Autonomix advances pancreatic cancer treatment system By Investing.com - Investing.com South Africa
Autonomix Medical, Inc. Advances Toward U.S. Clinical Trials in 2025 with Completed Integration of Apex 6 Generator for Transvascular Ablation - The Manila Times
Autonomix Medical Achieves Design Lock for Apex 6 Radiofrequency Generator, Advances Towards U.S. Clinical Trials for Pancreatic Cancer Pain Treatment - Nasdaq
Autonomix Medical, Inc. Advances Toward U.S. Clinical - GlobeNewswire
Autonomix Achieves Critical Milestone: FDA-Cleared Technology Powers New Cancer Pain Treatment System - StockTitan
Autonomix stock plunges to 52-week low of $2.23 amid market challenges - Investing.com Australia
Autonomix stock plunges to 52-week low of $2.23 amid market challenges By Investing.com - Investing.com South Africa
Autonomix Medical (NASDAQ:AMIX) versus Adagio Medical (NASDAQ:ADGM) Head-To-Head Review - Defense World
Autonomix Medical, Inc. Announces Abstract Highlighting Technology And Early Proof-Of-Concept Study Results Accepted At The Society Of Interventional Radiology (SIR) Annual Scientific Meeting - MENAFN.COM
Autonomix Medical, Inc. Announces Abstract Highlighting Technology and Early Proof-of-Concept Study Results Accepted at the Society of Interventional Radiology (SIR) Annual Scientific Meeting - GlobeNewswire
1.79%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):